Disease control rate at 8 weeks predicts subsequent survival in platinum-treated extensive stage small cell lung cancer: Results from the Southwest Oncology Group (SWOG) database

BACKGROUND: Overall response rate is frequently used as an endpoint in phase II trials of platinum-treated extensive stage small-cell lung cancer (ES-SCLC). We hypothesized that disease control rate (DCR) would be a superior surrogate for subsequent survival outcomes. METHODS: Updated patient-level...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Clin Lung Cancer
Κύριοι συγγραφείς: Lara, Primo N., Moon, James, Redman, Mary W., Semrad, Thomas J., Kelly, Karen, Allen, Jeffrey, Gitlitz, Barbara, Mack, Philip C., Gandara, David R.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2015
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4789142/
https://ncbi.nlm.nih.gov/pubmed/26498504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2015.09.003
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια